88IV - PR Newswire Asia's news - Biotechnology

< Previous page

| Title only | Print

Next page >

Dizal's ZEGFROVY® (Sunvozertinib) New Drug Application Accepted and Granted Priority Review by China National Medical Products Administration for First-Line Treatment of EGFR Exon 20 Insertion-Mutated Non-Small Cell Lung Cancer SHANGHAI , May 27, 2026 /PRNewswire/ -- Dizal (SSE:688192), a biopharmaceutical company committed to developing novel medicines for the treatment of oncology and hematological diseases, announced that ... 2026-05-27T Biotechnology Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
Announcement of The Shaw Laureates 2026 HONG KONG , May 27, 2026 /PRNewswire/ -- The Shaw Prize in Astronomy is awarded in equal shares to ... 2026-05-27T Biotechnology Computer/Electronics Education Health Care/Hospital
WuXi Biologics Achieves GMP Release of 18th Drug Product Facility, Advancing Integrated Drug Substance to Drug Product Capabilities SHANGHAI , May 27, 2026 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), announced that its Drug Product Facility 15 (DP15), ... 2026-05-27T Banking/Financial Service Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Insilico Medicine and Human Longevity Announce Collaboration to Co-Develop Industry-First AI Foundation Model for Longevity Science Cambridge, Mass. , May 26, 2026 /PRNewswire/ -- Insilico Medicine ("Insilico", 3696.HK), a clinical-stage generative artificial intelligence (AI)-driven biotechnology company, and Human Life ... 2026-05-26T Biotechnology Computer/Electronics Health Care/Hospital Medical/Pharmaceuticals
Deepening Focus on Autoimmune Diseases, Empowering AI-Driven Drug Discovery HkeyBio Builds a High-Efficiency Wet-Lab Validation Engine with Comprehensive CRO Service Upgrades in 2026 ... 2026-05-26T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
SK bioscience Signs Vaccine Technology Transfer Agreement with Colombia's VECOL to Advance Local Vaccine Manufacturing in Latin America SK bioscience collaborates with Colombia's government-led US$260 million vaccine localization initiative through technology transfer and local manufacturing cooperation with state-owned pharmaceutical ... 2026-05-26T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Kazia Therapeutics Expands Ongoing Phase 1b Trial of Paxalisib in Advanced Breast Cancer Planned Enrollment to Increase from 12 to 36 Patients Following Continued Encouraging Safety and Tolerability Data ... 2026-05-26T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
HanchorBio Prices IPO at NT$120 Ahead of Innovation Board Listing on May 29 TAIPEI and SHANGHAI and SAN FRANCISCO , May 26, 2026 /PRNewswire/ -- HanchorBio, Inc. (TPEx: 7827), a global clinical-stage biotechnology company advancing next-generation immunotherapies for oncology ... 2026-05-26T Banking/Financial Service Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Lundbeck receives marketing authorization for Vyepti® (eptinezumab) in South Korea for the preventive treatment of migraine Approval granted by South Korea's Ministry of Food and Drug Safety (MFDS) Eptinezumab is an anti-calcitonin gene-related peptide (CGRP) monoclonal antibody for the preventive treatment of migraine in ... 2026-05-26T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Over 40 Studies Featuring Akeso's Innovative Oncology Agents to Be Presented at ASCO 2026: Ivonescimab's HARMONi-6 Overall Survival Data Selected for Plenary Session HONG KONG , May 26, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") a nnounced that more than 40 clinical studies of its oncology portfolio will be presented ... 2026-05-26T Biotechnology Health Care/Hospital Medical/Pharmaceuticals

< Previous page

Next page >

88iv | Home | Login

Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer

Copyright (C) 2026

Suntek Computer Systems Limited.

All rights reserved